We have something new up our sleeve for you.

Dec. 1, 2002
2 min read
Mlo Generic Mlo Logo
We plan on using a variety of first-rate sources to prepare LABline. For example, we might run a condensed version of a New York Times story on a study published in the New England Journal of Medicine which shows how testing for C-reactive protein may be better than cholesterol testing for predicting risk of heart attack or stroke. Researchers, led by Dr. Paul M. Ridker of Bostons Brigham and Womens Hospital, found that women with high C-reactive protein were twice as likely as women with high cholesterol to suffer a heart attack or stroke. Or you might see an item about the National Institutes of Health spending part of its $1.8billion biological warfare defense budget on 10 counterterror labs, two of them in the Washington, D.C., area.This is the kind of quick news that youll get when you subscribe to MLOs new LABline. Along with clinical news, youll also get regulatory and legislative news as well as industry updates.Give it a try. To sign up, go to our website at www.mlo-online.com. LABline will hit your Inbox promptly on Jan. 2. Be sure to let us know what you think, especially the types of articles youd like to see. Were excited about this new publication, and we hope you will be, too.
Wishing you all good things this holiday season.Celia Stevens
[email protected]©
2002 Nelson Publishing, Inc. All rights reserved.

About the Author

MLO Staff

MLO Staff

Sign up for Medical Laboratory Observer eNewsletters

Related

Peter Bach, MD, Chief Medical Officer of DELFI Diagnostics discusses blood test for lung cancer detection
The utility of polymerase chain reaction testing for urinary tract infections
A Fresh Look at Temperature Tracking Accuracy
Sponsored
A Cancer Center’s Path to Smarter Monitoring
Sponsored